Physical effects of cholesterol on arterial smooth muscle membranes: Evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis

Journal of Lipid Research

Volumn 39, Issue 5, 1998, Pages 947-956

  Tulenko, Thomas N ^a   Chen, Meng ^a   Mason, Pamela E ^a   Mason, R Preston ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Heart disease; Membrane structure; Phospholipids; Vascular disease; X ray diffraction

Indexed keywords

CHOLESTEROL; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; ATHEROGENESIS; CELL FUNCTION; CHOLESTEROL INTAKE; HEART DISEASE; LIPID METABOLISM; NONHUMAN; PERIODICITY; PHENOTYPE; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; RABBIT; REPRODUCIBILITY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; X RAY DIFFRACTION;

ANIMALS; ARTERIOSCLEROSIS; CELL MEMBRANE; CHOLESTEROL; DIET, ATHEROGENIC; LIPID BILAYERS; MUSCLE, SMOOTH, VASCULAR; RABBITS; X-RAY DIFFRACTION;

EID: 0031899062     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Bloch K. 1983. Sterol structure and membrane function. Crit. Rev. Biochem. 14: 47-92.
2. Broderick, R., R. A. Bialecki, and T. N. Tulenko. 1989. Cholesterol-induced changes in arterial sensitivity to adrenergic stimulation. Am. J. Physiol. 257: H170-H178.
3. Bialecki, R. A., and T. N. Tulenko. 1989. Excess membrane cholesterol alters calcium channels in arterial smooth muscle. Am. J. Physiol. 257: C306-C314.
4. Chen, M., R. P. Mason, and T. N. Tulenko. 1995. Atherosclerosis alters composition, structure and function of arterial smooth muscle plasma membranes. Biochim. Biophys. Acta. 1272: 101-112.
5. Yeagle, P. L. 1985. Cholesterol and cell membranes. Biochim. Biophys. Acta. 822: 267-287.
6. Leonard, A., and E. J. Dufourc. 1991. Interactions of cholesterol with the membrane lipid matrix. A solid state NMR approach. Biochimie. 73: 1295-1302.
7. Evans, E., and D. Needham. 1987. Physical properties of surfactant bilayer membranes: thermal transition, elasticity, rigidity, cohesion and colloidal interactions. J. Phys. Chem. 91: 4219-4228.
8. Needham, D., and R. S. Nunn. 1990. Elastic deformation and failure of lipid bilayer membranes containing cholesterol. Biophys. J. 58: 997-1009.
9. McIntosh, T. J. 1978. The effect of cholesterol on the structure of phosphatidylcholine bilayers. Biochim. Biophys. Acta. 513: 43-58.
10. 2+ channel blockers to the membrane lipid bilayer. Mol. Pharmacol. 41: 315-321.
11. Ruocco, M. J., and G. G. Shipley. 1984. Interaction of cholesterol with galactocerebroside and galactocerebroside-phosphatidylcholine bilayer membranes. Biophys. J. 46: 695-707.
12. Craven, B. M. 1976. Crystal structure of cholesterol monohydrate. Nature. 260: 727-729.
13. Mantripragada, B. S., and T. E. Thompson. 1991. Cholesterol-induced fluid-phase immiscibility in membranes. Proc. Natl. Acad. Sci. USA. 88: 8686-8690.
14. Rice, P. A, and H. M. McConnell. 1989. Critical shape transitions of monolayer lipid domains. Proc. Natl. Acad. Sci. USA. 86: 6445-6448.
15. Kannel, W. B., W. P. Castelli, and T. Gordon. 1979. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann. Intern. Med. 90: 85-91.
16. Kannel, W. B., J. D. Neaton, and D. Wentworth. 1986. Overall coronary heart disease mortality rate in relation to major risk factors in 325,348 men screened for the MRFIT. Am. Heart. J. 112: 825-836.
17. 2+ movements and vasoconstriction in atherosclerotic aorta. Arterioscler. Thromb. 14: 1854-1859.
18. Christie, W. W. 1982. A simple procedure for rapid transmethylation of glycerolipids and cholesteryl esters. J. Lipid. Res. 23: 1072-1075.
19. Gleason, M. M., M. S. Medow, and T. N. Tulenko. 1991. Excess membrane cholestorel alters calcium movements, cytosolic calcium levels, and membrane fluidity in arterial smooth muscle cells. Circ. Res. 69: 216-227.
20. Tsukada, T., D. Tippens, D. Gordon, R. Ross, and A. M. Gown. 1987. HHF-35, a muscle-actin-specific monoclonal antibody. Am. J. Pathol. 126: 51-60.
21. Tsukada, T., M. E. Rosenfield, R. Ross, and A. M. Gown. 1986. Immunocytochemical analysis of cellular components in atherosclerotic lesions. Use of monoclonal antibodies with the Watanabe and fat-fed rabbits. Arteriosclerosis. 6: 601-613.
22. O'Neill, R. G., and W. P. Dubinsky. 1984. Micromethodology for measuring ATPase activity in renal tubules: mineralocorticoid influence. Am. J. Physiol. 247: C314-C320.
23. Beaufay, G., A. Amar-Costesec, E. Feytmans, D. Thines-Semponx, M. Wibo, and J. Berthet. 1974. Analytical studies of microsomes and isolated subcellular membranes from rat liver. J. Cell Biol. 61: 188-200.
24. Cooperstein, S., and A. Lazarow. 1951. A microspectrophotometric method for the determination of cytochrome oxidase. J. Biol. Chem. 189: 665-670.
25. Harrison, E. H., and W. E. Bowers. 1983. Characterization of rat lymphocyte cell membranes by analytical isopynic centrifugation. J. Biol. Chem. 258: 7134-7140.
26. Labarka, C., and K. Paigen. 1980. A simple, rapid and sensitive DNA assay procedure. Anal. Biochem. 102: 344-352.
27. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
28. Sokoloff, L., and G. H. Rothblat. 1974. Sterol to phospholipid molar ratio of L-cell with qualitative and quantitative variations of cellular sterol. Proc. Soc. Exp. Biol. Med. 146: 1166-1172.
29. Chester, D. W., L. G. Herbette, R. P. Mason, A. F. Joslyn, D. J. Triggle, and D. E. Koppel. 1987. Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multilayers. Biophys. J. 52: 1021-1030.
30. Weglicki, W. B., K. Owens, F. F. Kennet, A. Kessner, L. Harris, and R. M. Wise. 1980. Preparation and properties of highly enriched cardiac sarcolemma from isolated adult myocytes. J. Biol. Chem. 255: 3605-3609.
31. Herbette, L. G., T. MacAlister, T. F. Ashavaid, and R. A. Colvin. 1985. Structure-function studies of canine cardiac sarcolemmal membranes. II. Structural organization of the sarcolemmal membrane as determined by electron microscopy and lamellar X-ray diffraction. Biochim. Biopliys. Acta. 812: 609-623.
32. Mason, R. P., and D. W. Chester. 1989. Diffusional dynamics of an active rhodamine-labeled 1,4-dihydropyridine in sarcolemmal lipid multilayers. Biophys. J. 56: 1193-1201.
33. Harris, J. S., D. E. Epps, S. R. Davis, and F. J. Kezdy. 1996. Evidence for transbilayer, tail-to-tail cholesterol dimers in dipalmitoylglycerophosphocholine liposomes. Biochemistry. 34: 3851-3857.
34. Lange, Y., M. H. Swaisgood, B. V. Ramos, and T. L. Steck. 1989. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblast. J. Biol. Chem. 264: 3786-3793.
35. + channels in smooth muscle cells isolated from normal and atherosclerotic human aorta. Proc. R. Soc. London. Series-B. 244: 51-55.
36. +)-ATPase hydrolyzing activity in the human erythrocyte. Biochim. Biophys. Acta. 727: 39-44.
37. + pump in endothelial cells. Atherosclerosis. 110: 251-257.
38. +)-ATPase ATP hydrolyzing activity in bovine kidney. Biochemistry. 27: 6449-6452.
39. Chang, H. M., R. Reitstetter, R. P. Mason, and R. Gruener. 1995. Attenuation of channel kinetics and conductance by cholesterol: an interpretation using structural stress as a unifying concept. J. Membr. Biol. 143: 51-63.
40. Schroeder, F., and W. G. Wood. 1995. Lateral lipid domains and membrane function. In Cell Physiology Source Book. N. Sperelakis, editor. Academic Press, New York. 36-44.
41. Tocanne, J. F. 1992. Detection of lipid domains in biological membranes. Comments Mol. Cell. Biophys. 8: 53-72.
42. o cholesterol in liposomes. Biochim. Biophys. Acta. 1109: 81-90.
43. Mohwald, H., A. Dietrich, C. Bohm, G. Brezesinski, and M. Thoma. 1995. Domain formation in monolayers. Mol. Membr. Biol. 12: 29-38.
44. Bloom, M., and J. L. Thewalt. 1995. Time and distance scales of membrane domain organization. Mol. Membr. Biol. 12: 9-13.
45. Hui, S. W. 1995. Geometry of domains and domain boundaries in monolayers and bilayers. Mol. Membr. Biol. 12: 45-50.
46. Rothblat, G. H., F. H. Mahlberg, W. J. Johnson, and M. C. Phillips, 1992. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J. Lipid. Res. 33: 1091-1097.
47. Schroeder, F., J. R. Jefferson, A. B. Kier, J. Knittel, T. J. Scallen, W. G. Wood, and I. Hapala. 1991. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc. Soc. Exp. Biol. Med. 195: 235-252.
48. Schroeder, F., A. A. Frolov, E. J. Murphy, B. P. Atshaves, J. R. Jefferson, L. Pu, et al. 1996. Recent advances in membrane cholesterol domain dynamics and intracellular cholesterol trafficking. Proc. Soc. Exp. Biol. Med. 213: 150-177.
49. Phillips, M. C., W. C. Johnson, and G. R. Rothblat. 1997. Mechanism and consequences of cellular cholesterol exchange and transfer. Biochim. Biophys. Acta. 906: 223-276.
50. Bialecki, R. A., T. N. Tulenko, and W. S. Colucci. 1991. Cholesterol enrichment increases basal and agonist-stimulated calcium influx in rat vascular smooth muscle. J. Clin. Invest. 88: 1894-1900.
51. Tulenko, T. N., L. Laury-Kleintop, M. F. Walter, and R. P. Mason. 1997. Cholesterol, calcium and atherogenesis. Is there a role for calcium channel blockers in atheroprotection? Int. J. Cardiol. 62: 55-64.